The earnings release referenced on this call as well as the associated 10-Q can be found in the Investor section of our website verisk.com. The earnings release has also been attached to an 8-K that we have furnished to the SEC. A replay of this call will be posted on our website and available by dial-in for 30 days until September 1, 2012.
Finally, as set forth in more detail in today’s earnings release, I will remind everyone that today’s call may include forward-looking statements about Verisk’s future performance. Actual performance could differ materially from what is suggested by our comments today. And information about the factors that could affect future performance is summarized at the end of our press release as well as contained in our recent SEC filings.
And with that, I will now turn the call over to Frank Coyne.
Frank CoyneThank you, Eva, and good morning. In second quarter 2012, we delivered good performance of 14% total revenue growth and almost 15% diluted adjusted EPS growth. We continued strong performance from our Healthcare business and good performance from our insurance businesses and our emerging businesses in specialized markets. In the second quarter our risk adjustment revenue grew 4.9% after adjusting for the impact of a transfer of some revenue to Decision Analytics beginning in 2012. This growth is a continuation of what you saw in the first quarter and evidence of our sticky customer relationship based on the recognizable value we bring. In Decision Analytics, we grew revenue almost 23% and our insurance solutions in Decision Analytics grew about 9%, a very solid rate given the lower storm activity versus last year. Our Healthcare solutions continued on the organic growth we have seen in the past few quarters growing revenue nearing 37% organically in the quarter. Our total Healthcare revenue growth was over 160% bolstered by the contributions MediConnect has made to our second quarter performance.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts